Context Owing to population ageing, a growing number of kidney transplants (KTs) in elderly
population are being performed. KT is the best treatment for patients with end-stage renal …

Background. Cardiovascular disease is a frequent complication after kidney transplantation
and represents the leading cause of mortality in this population. Material and Methods. We …

Cardiovascular disease remains a leading cause of morbidity and mortality after kidney
transplantation (KT). Although statins reduce cardiovascular risk and have renal benefits in …

Fabry disease is an X-linked inheritable lysosomal storage disease caused by various
mutations of the galactosidase α gene resulting in α-galactosidase deficiency. Chronic …

Background. Glucagon-like peptide 1 receptor agonists (GLP1-RAs) reduce cardiovascular
events and mortality in type 2 diabetes. Limited data are available on diabetes treatment …

Kidney transplant recipients (KTR) are at increased risk of cardiovascular mortality. We
investigated whether, in KTR, post-transplantation copper status is associated with the risk of …

Major adverse cardiovascular event (MACE) rates immediately after kidney transplantation
remain uncertain due to heterogeneous reporting in the literature. To clarify this, we …

Kidney transplantation is the therapy of choice for patients with end-stage renal disease.
Preexisting diabetes is highly prevalent in kidney transplant recipients (KTR), and the …

Background Induction of donor-specific tolerance is a promising approach to achieve long-
term graft patency in transplantation with little to no maintenance immunosuppression …

It is well established that age-adjusted rates of myocardial infarction and stroke have been
falling in the general population. 1, 2 This is in part due to primary and secondary prevention …